Arash Zarrine-Afsar

Dr. Arash Zarrine-Afsar


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2012 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
AZArash Zarrine-Afsar
Arash Zarrine-Afsar
TBThomas R. M. Barends
Thomas R. M. Barends
CMChristina Müller
Christina Müller
MFMartin Fuchs
Martin Fuchs
LLLukas Lomb
Lukas Lomb
CMC. Mueller
C. Mueller

13 October 2016 in Scientific Reports
Verified
Journal Article
Open access
ATAlessandra Tata
Alessandra Tata
MWMichael Woolman
Michael Woolman
MVManuela Ventura
Manuela Ventura
NBNicholas Bernards
Nicholas Bernards
MGMilan Ganguly
Milan Ganguly
AZArash Zarrine-Afsar
Arash Zarrine-Afsar
Identification of necrosis in tumors is of prognostic value in treatment planning, as necrosis is associated with aggressive forms of cancer and unfavourable outcomes. To facilitate rapid detection of necrosis with Mass Spectrometry (MS), we report the lipid MS profile of necrotic breast cancer with Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) imaging validated with statistical analysis and correlating pathology. This MS profile is characterized by (1) the presence of the ion of m/z 572.48 [Cer(d34:1) + Cl]− which is a ceramide absent from the viable cancer subregions; (2) the absence of the ion of m/z 391.25 which is present in small abundance only in viable cancer subregions; and (3) a slight increase in the relative intensity of known breast cancer biomarker ions of m/z 281.25 [FA(18:1)-H]− and 303.23 [FA(20:4)-H]−. Necrosis is accompanied by alterations in the tissue optical depolarization rate, allowing tissue polarimetry to guide DESI-MS analysis for rapid MS profiling or targeted MS imaging. This workflow, in combination with the MS profile of necrosis, may permit rapid characterization of necrotic tumors from tissue slices. Further, necrosis-specific biomarker ions are detected in seconds with single MS scans of necrotic tumor tissue smears, which further accelerates the identification workflow by avoiding tissue sectioning and slide preparation.

23 November 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
JZJing Zou
Jing Zou
FTFrancis Talbot
Francis Talbot
ATAlessandra Tata
Alessandra Tata
LELeonardo Ermini
Leonardo Ermini
KFKresimir Franjic
Kresimir Franjic
AZArash Zarrine-Afsar
Arash Zarrine-Afsar

21 July 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
MWMichael Woolman
Michael Woolman
IFIsabelle Ferry
Isabelle Ferry
CKClaudia M. Kuzan-Fischer
Claudia M. Kuzan-Fischer
MWMegan Wu
Megan Wu
JZJing Zou
Jing Zou
AZArash Zarrine-Afsar
Arash Zarrine-Afsar
Medulloblastoma (MB), the most prevalent malignant childhood brain tumour, consists of at least 4 distinct subgroups each of which possesses a unique survival rate and response to treatment. To rapidly determine MB subgroup affiliation in a manner that would be actionable during surgery, we subjected murine xenograft tumours of two MB subgroups (SHH and Group 3) to Mass Spectrometry (MS) profiling using a handheld Picosecond InfraRed Laser (PIRL) desorption probe and interface developed by our group. This platform provides real time MS profiles of tissue based on laser desorbed lipids and small molecules with only 5–10 seconds of sampling. PIRL-MS analysis of ex vivo MB tumours offered a 98% success rate in subgroup determination, observed over 194 PIRL-MS datasets collected from 19 independent tumours (∼10 repetitions each) utilizing 6 different established MB cell lines. Robustness was verified by a 5%-leave-out-and-remodel test. PIRL ablated tissue material was collected on a filter paper and subjected to high resolution LC-MS to provide ion identity assignments for the m/z values that contribute most to the statistical discrimination between SHH and Group 3 MB. Based on this analysis, rapid classification of MB with PIRL-MS utilizes a variety of fatty acid chains, glycerophosphates, glycerophosphoglycerols and glycerophosphocholines rapidly extracted from the tumours. In this work, we provide evidence that 5–10 seconds of sampling from ex vivo MB tissue with PIRL-MS can allow robust tumour subgroup classification, and have identified several biomarker ions responsible for the statistical discrimination of MB Group 3 and the SHH subgroup. The existing PIRL-MS platform used herein offers capabilities for future in vivo use.

17 July 2015 in Analytical Chemistry
Verified
Journal Article
Open access
MCMartin F. Czar
Martin F. Czar
FZFranziska Zosel
Franziska Zosel
IKIwo König
Iwo König
DNDaniel Nettels
Daniel Nettels
BWBengt Wunderlich
Bengt Wunderlich
RJRebecca A. Jockusch
Rebecca A. Jockusch
Electrospray ionization and mass spectrometry have revolutionized the chemical analysis of biological molecules, including proteins. However, the correspondence between a protein’s native structure and its structure in the mass spectrometer (where it is gaseous) remains unclear. Here, we show that fluorescence (Förster) resonance energy transfer (FRET) measurements combined with mass spectrometry provides intramolecular distance constraints in gaseous, ionized proteins. Using an experimental setup which combines trapping mass spectrometry and laser-induced fluorescence spectroscopy, the structure of a fluorescently labeled mutant variant of the protein GB1 was probed as a function of charge state. Steady-state fluorescence emission spectra and time-resolved donor fluorescence measurements of mass-selected GB1 show a marked decrease in the FRET efficiency with increasing number of charges on the gaseous protein, which suggests a Coulombically driven unfolding and expansion of its structure. This lies in stark contrast to the pH stability of GB1 in solution. Comparison with solution-phase single-molecule FRET measurements show lower FRET efficiency for all charge states of the gaseous protein examined, indicating that the ensemble of conformations present in the gas phase is, on average, more expanded than the native form. These results represent the first FRET measurements on a mass-selected protein and illustrate the utility of FRET for obtaining a new kind of structural information for large, desolvated biomolecules.

15 December 2015 in Chemical Science
Verified
Journal Article
Open access
PDF file
ATAlessandra Tata
Alessandra Tata
AGAdam Gribble
Adam Gribble
MVManuela Ventura
Manuela Ventura
MGMilan Ganguly
Milan Ganguly
EBEmma Bluemke
Emma Bluemke
AZArash Zarrine-Afsar
Arash Zarrine-Afsar
While mass spectrometers can detect chemical signatures within milliseconds of data acquisition time, the non-targeted nature of mass spectrometry imaging (MSI) necessitates probing the entire surface of the sample to reveal molecular composition even if the information is only sought from a sample subsection. This leads to long analysis times. Here, we used polarimetry to identify, within a biological tissue, areas of polarimetric heterogeneity indicative of cancer. We were then able to target our MS analysis using polarimetry results to either the cancer region itself or to the cancer margin. A tandem of polarimetry and Desorption Electrospray Ionization Mass Spectrometry Imaging (DESI-MSI) enables fast (10 fold compared to non-targeted imaging), and accurate pathology assessment (cancer typification in less than 2 minutes compared to 30 minutes for histopathology) of ex vivo tissue slices, without additional sample preparation. This workflow reduces the overall analysis time of MSI as a research tool.